Supervisory Board

Conny Helder (1958) is a Dutch healthcare manager, who served as the Minister for Long-term Care and Sport and, for a few months, as Minister of Health, Welfare and Sport in the fourth Rutte cabinet (2022–2024).
She was born in The Hague and trained to be a surgical assistant. She rose to managerial positions in hospitals and served as chair of the board of directors of an Eindhoven network of primary healthcare centers starting in 2010. Helder became director of tanteLouise, a major provider of elderly care in the Bergen op Zoom area, seven years later and was involved in a number of projects to renovate existing and construct new nursing homes. She also led a regional cooperation to promote innovations in the elderly care sector. tanteLouise was heavily affected by the COVID-19 pandemic, which reached the Netherlands in February 2020. Helder, who had become a board member of the trade association ActiZ the month before, made frequent media appearances to comment on the pandemic and to advocate the association's positions.
When the fourth Rutte cabinet was formed, Helder was asked to join as Minister for Long-term Care and Sport on behalf of the centre-right People's Party for Freedom and Democracy (VVD). She was sworn in on 10 January 2022 and proposed a plan to provide more elderly care at home rather than in nursing homes in reaction to the aging population of the Netherlands. She succeeded Ernst Kuipers as Minister of Health, Welfare and Sport in January 2024 following his resignation and served in that position until July 2024.
Helder is driven by a passion for ensuring quality, accessible, and sustainable healthcare, and she brings this dedication to her role at RegMed XB. "Given the immense pressure on healthcare systems and the continually growing demand, I firmly believe that innovation and technology are crucial in easing this burden and creating a sustainable future for healthcare."
Koenraad Debackere
ProfileKoenraad Debackere is a professor of Technology and Innovation Management & Policy at KU Leuven since 1995. He has degrees in engineering and business. He was a visiting doctoral student and Fulbright post-doctoral fellow at MIT Sloan School and obtained best paper awards from the TIM Division of the American Academy of Management, the Decision Sciences Institute and the International Association for the Management of Technology. In 2006 he was awarded the Prize for Scientific Excellence of the Belgian Entreprise Foundation (VBO). In 2007 he received an honorary professorship from the Science Policy Research Unit at the University of Sussex.
He is the managing director of KU Leuven Research & Development and chairman of the KU Leuven seed fund, Gemma Frisius. He is co-founder and chairman of Leuven.Inc, the innovation network of Leuven high-tech entrepreneurs. Since 2005, he is the general manager of KU Leuven. In 2015, he was appointed chairman of EIT Health e.V. --- a KIC of the European Institute of Innovation and Technology.

Maurice Horsten
ProfileMaurice Horsten (1967) has a distinguished career in pharmaceuticals, medical devices, and biotechnology. He has worked for multinational companies like Eli Lilly & Company and Mediq NV in various countries and has also been a successful entrepreneur. In 2006, he and his business partner sold medical device supplier DiabetesDirect to Mediq NV. Later, he was an investor and CEO of PharmaCell, a biotech company in regenerative medicine, which was successfully sold to Lonza SA. Currently, Maurice is the Director of the NV Bossche Investment Company (BIM), where he has extensive experience managing public investment companies and established the Bossche Investment Fund (BIF). As a board member of Braventure, he has worked on enhancing the start-up ecosystem. He also served on the board of the Limburg University Fund for nearly 10 years.
In the life sciences sector, Maurice serves on the supervisory boards of Brabant Life Sciences Seed Fund and Basic Pharma BV. For the province of Brabant, he is the chairman of the Leisure Development Fund Brabant, the supervisory board of NV Monumenten Beheer Brabant, and a member of the supervisory board of Van Gogh Sites NV. He is honored to contribute to RegMed XB’s Supervisory Board, supporting the growth of regenerative medicine, which he sees as having great potential.

Floris Italianer
ProfileFloris Italianer has worked in the healthcare and non-profit sectors over the last 20 years. Next to his role in our Supervisory Board, he is serving as the Chairman of the Supervisory Board at Pathan Laboratories, a pathology laboratory supporting Dutch hospitals and primary care centers.
Previously, Italianer was the Managing Director of Erasmus Universiteit Rotterdam Convergence (2022-2023), a collaborative initiative with TU Delft and Erasmus MC focused on addressing complex societal challenges. He also served as the CEO of the Dutch Heart Foundation from 2013 to 2022, advancing efforts against cardiovascular diseases, and was Chairman of the Dutch CardioVascular Alliance and the European Heart Network during pivotal years (2019-2022), fostering cooperation among organizations dedicated to heart health. His governance experience extends to roles such as board member for various organizations, including the World Heart Federation, where he contributed to global cardiovascular health initiatives, and as a board member for the Gezondheidsfondsen voor Rookvrij, advocating for a smoke-free generation. Italianer’s early career includes notable positions at Point of Vision Group and Accenture, where he shaped strategies in healthcare and media. Italianer holds an MBA from the Rotterdam School of Management and has pursued various training programs in supervisory board roles and mediation. With a commitment to improving healthcare systems and championing public health initiatives, Floris Italianer combines his expertise in management with a passion for making a meaningful impact in society.
Arno van Son
ProfileArno van Son has over 20 years of experience in the healthcare sector, contributing significantly to various organizations. He served as a member of the Board of Directors at CZ Groep from 2010 to 2022, one of the leading healthcare insurers in the Netherlands.
Prior to his role at CZ Groep, Arno was the Director of Medicinfo from 2001 to 2013, where he led efforts to enhance information accessibility in healthcare. He also held the position of Director at Vecozo from 2002 to 2011, where he focused on improving data exchange in the healthcare sector. His leadership extended to the role of Chairman of the Annual General Meeting at Opera Consultancy & Implementatie from 2009 to 2011, driving projects that facilitated effective healthcare implementations. From 2007 to 2010, he served as Director of the WMO Office, focusing on the integration of healthcare and social services. His tenure included the acquisition of healthcare insurance portfolios for Delta Lloyd Group from 2007 to 2009. Earlier in his career, Arno held key positions at CZ, including Director of Commercial Affairs from 1999 to 2001 and Director of Operational Affairs from 1990 to 1999, where he played a role in enhancing operational efficiency and customer satisfaction. Arno van Son is dedicated to improving healthcare systems and is passionate about fostering innovation in healthcare delivery.